Results 191 to 200 of about 27,995 (239)

How the Reclassification of Gabapentinoids Reshaped Neuropathic Pain Treatment in Saudi Arabia: A Survey of Healthcare Professionals. [PDF]

Pain Ther
Kaki A, Hamdy Y, Amir A.
europepmc   +1 more source

Misuse of Pregabalin and Gabapentin: A Second Systematic Review Update. [PDF]

Drugs
Evoy KE, Drain D, Pedigo J, Covvey JR, Ramey O.   +4 more
europepmc   +1 more source

Concurrent utilization of pregabalin and Zhengqing fengtongning sustained-release tablets in managing postherpetic neuralgia and its effect on pain relief, VAS scores, Insomnia Severity Index (ISI), SF-36, serum interleukin-17 (IL-17), prostaglandin E2 (PGE2). [PDF]

Postepy Dermatol Alergol
Luo H, Zhang W, Qiao M, Xin L.
europepmc   +1 more source

Pregabalin enhances the proliferative potential of pancreatic cancer in vitro but not in mice with pancreatic cancer. [PDF]

BMC Pharmacol Toxicol
Itaya T, Sano M, Kajiwara I, Oshima Y, Kuramochi T, Kim J, Kitajima O, Ijichi H, Suzuki T.   +8 more
europepmc   +1 more source

Topical Pregabalin in Burning Mouth Syndrome: A Real-World Study of Peripheral Neuromodulation. [PDF]

Medicina (Kaunas)
Canfora F, Argiuolo A, Salerno S, Castellucci C, Evangelista R, Ferrara S, Valletta R, De Rosa A, Memè L, Mignogna MD, Adamo D.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Pregabalin

Reactions Weekly, 2006
Each month, subscribers to The Formulary Monograph Service receive five to six well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to your Pharmacy and Therapeutics Committee. Subscribers also receive monthly one-page summary monographs on the agents that are useful for agendas and ...
Dennis J. Cada, Terri Levien, Danial E. Baker   +2 more
  +5 more sources